AI Tools | Submit AI Tool | AI News | AI Courses | YouTube
Andrew Garfield is playing Sam Altman. 👀
That’s a sentence I didn’t expect to write this week. Apparently, the AI world has officially become interesting enough to get its own movie.
And that’s just the beginning.
Here's what else happened in AI while you were busy.
Andrew Garfield is becoming Sam Altman
Google AI is hunting for disease in your DNA
Apple’s iPhone 18 gets an AI defense
Apple’s Foldable Duo hinge was built with AI
An AI-designed drug takes on aging
An Anthropic researcher quits over AI safety fears
3 AI tools for smarter workflows
"AI is a tool. The choice about how it gets deployed is ours."
— Oren Etzioni
The best in influencer marketing. And you’re invited.
Get ready for Return on Influence Festival '26. An entire day dedicated to influencer marketing with speakers running some of the best programs in the world. October 21, 2026, 10 am - 5 pm ET.
👀AI Tools for Smarter Workflows
ReportPDF: Turns reports and documents into useful insights, helping you work through complex information faster.
Scanflow AI: Uses AI-powered visual inspection to spot defects, track assets, and improve quality control across industrial workflows.
ScanIt: Helps logistics teams scan shipments and inventory, track goods in real time, and reduce manual data-entry errors.
Did you know?
Your business could unlock up to $5,000 in AWS credits (plus up to $400K in other software credits), if you claim them the right way. Learn exactly how in our pre-recorded course.
Price: Just $29 (Original Price $97)
Have a question first? Reply anytime, happy to help you before and after your purchase. I read and reply every email.
Advertise In AIChief Newsletter
Put Your Brand in Front of 150K Active AI Users
Claim Your Spot
🆕 AI’s Latest Drops
Finding the DNA change behind a rare disease is like trying to find a needle in a haystack. Google DeepMind’s AlphaGenome Atlas maps the predicted effects of 9 billion possible DNA changes, and researchers have already used it to uncover a disease-linked variant that earlier work missed.
Sam Altman’s OpenAI drama is officially heading to Hollywood. Andrew Garfield stars as Altman in Artificial, a new film about the leadership fight that shook OpenAI and the events surrounding Altman’s firing and return.
Apple’s new Reference Mode creates an unalterable version of a photo that users can compare with edited copies. It gives iPhone 18 Pro users a way to check whether an image has been changed by AI or other editing tools.
Apple’s new Foldable Duo is bringing AI into one of the phone’s trickiest parts: the hinge. AI helps match each hinge with its best-fit housing, while 3D printing adds tiny layers to smooth out imperfections and improve durability.
AI's next bottleneck
AI is not just a software story.
It is an infrastructure story.
Data centers need chips, power, cooling, networking, electrical systems, nuclear energy, and real estate.
That is why we created a free StockEarnings briefing on 9 public stocks tied to the data-center boom.
The report shows which companies may be positioned near the biggest bottlenecks — and what investors should watch before the story gets more crowded.
The full 9-stock map is here.
No hype.
No penny stocks.
Just a clear framework for understanding the companies powering AI infrastructure.
Here is the free copy.
An Anthropic researcher has quit the company after becoming increasingly worried about where the AI race is heading.
Jacob Coxon, who previously worked at OpenAI, says both companies are racing toward self-improving AI without fully understanding the risks. He argues that the push to build increasingly powerful systems is moving faster than efforts to keep them under control.
What makes this stand out is that Coxon wasn’t watching the AI race from the outside. He was working inside it.
Scroll Break
An AI-designed drug for lung disease is now showing a surprising signal around aging.
Researchers tested rentosertib in a clinical trial and used six protein-based aging clocks to measure changes in biological age. All six showed lower predicted biological age in the treatment groups.
It’s not proof that the drug slows aging, but the result has researchers taking a closer look at what this AI-designed drug might be doing beyond treating lung disease.
Thank you for reading!
We hope these AI insights help you start the week strong. Don’t forget to share what you’ve learned with friends, family, and colleagues. 📚✨
For more AI updates, follow us on X, LinkedIn, and YouTube.
See you soon!
— Team AIChief
